title: Predicting outcome from post-transplant lymphoproliferative disease: a risky business.
authors.forename: M
authors.initials: M
authors.lastname: Green
authors.forename: M
authors.initials: M
authors.lastname: Michaels
authors.forename: S
authors.initials: S
authors.lastname: Weber
mesh_terms: D016026:Bone Marrow Transplantation / Q000009:adverse effects* / Q000401:mortality; D002648:Child; D004854:Herpesvirus 4, Human / Q000472:pathogenicity; D006801:Humans; D007165:Immunosuppression Therapy / Q000009:adverse effects; D015994:Incidence; D008232:Lymphoproliferative Disorders / Q000209:etiology* / Q000401:mortality / Q000821:virology; D016377:Organ Transplantation / Q000009:adverse effects* / Q000401:mortality; D011237:Predictive Value of Tests; D012307:Risk Factors; D016896:Treatment Outcome